Answers are grounded in this paper and cite their sources.
The choice of surgical treatment for patients with severe subarachnoid hemorrhage due to cerebral aneurysm (CA) rupture remains one of the key challenges in vascular neurosurgery. The widespread introduction of endovascular technology into clinical practice allowed to slightly change the paradigm of surgical treatment of ruptured cerebral aneurysms, making it possible to rapidly and practically atraumatically exclude aneurysms regardless of the initial severity in patients. However, the availability of endovascular (EV) interventions and the high cost of the procedure are limiting factors. STUDY OBJECTIVE: to evaluate the treatment outcomes of patients with aneurysmal subarachnoid hemorrhage (aSAH) of high severity (IV and V according to WFNS) depending on the method of aneurysm exclusion from the blood flow. MATERIALS AND METHODS: From 2010 to 2020, a prospective study including two patient groups was performed: Group 1 comprised 100 patients with SAH of aneurysmal etiology who underwent endovascular occlusion of the ruptured aneurysm cavity, and Group 2 included 35 patients who underwent microsurgical clipping. All the patients were evaluated according to the accepted clinical and instrumental scales, and investigations were performed accordg to the standards of medical care. OUTCOMES AND DISCUSSION: The patients enrolled in both study groups were comparable in terms of baseline severity. Immediate treatment outcomes were better in the endovascular group. Our study demonstrated the applicability of this statement in patients with severe aSAH. However, the effect of aneurysm exclusion procedure on patient survival during treatment has not been established. The risk of intraoperative complications in both endovascular and microsurgical groups is low, and the radicality degree of aneurysm exclusion is significantly higher in the microsurgical clipping group. CONCLUSIONS: The EV and MC remain complementary treatment modalities for the ruptured cerebral aneurysms. When choosing the treatment method, if both procedures are available, intravascular interventions should be given priority in patients with severe aSAH, especially in the presence of sub- or decompensated somatic pathology (long history of diabetes mellitus and arterial hypertension).
No takes yet. Share an insight, caveat, or question.
Ermakov et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: